11:56 AM EST - Nuvo Pharmaceuticals Inc. : Announced that its wholly owned subsidiary, Aralez Pharmaceuticals Canada Inc. (Aralez Canada) has launched Suvexx into the approximately $130-million Canadian prescription acute migraine market. Nuvo Pharmaceuticals Inc.
shares T.NRI are trading down $0.01 at $0.75.
